Release Date: 17/01/14 10:14 Summary: Eldorado regulatory conditions freed & GLY Directors accept Price Sensitive: No Download Document 97.69KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%